UnitedHealth Group Incorporated (NYSE:UNH) is Ulland Investment Advisors LLC's 6th Largest Position

Ulland Investment Advisors LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 25.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,356 shares of the healthcare conglomerate's stock after selling 3,129 shares during the period. UnitedHealth Group makes up about 4.1% of Ulland Investment Advisors LLC's holdings, making the stock its 6th largest holding. Ulland Investment Advisors LLC's holdings in UnitedHealth Group were worth $4,900,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in the stock. Capital & Planning LLC grew its position in UnitedHealth Group by 19.2% in the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock worth $248,000 after acquiring an additional 79 shares during the period. Brighton Jones LLC lifted its stake in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Union Bancaire Privee UBP SA acquired a new position in UnitedHealth Group during the fourth quarter worth $27,233,000. Revolve Wealth Partners LLC lifted its stake in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Finally, Quent Capital LLC lifted its stake in UnitedHealth Group by 3.4% during the fourth quarter. Quent Capital LLC now owns 4,250 shares of the healthcare conglomerate's stock worth $2,150,000 after purchasing an additional 140 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Stephen J. Hemsley bought 86,700 shares of the firm's stock in a transaction on Friday, May 16th. The stock was purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer now owns 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer now owns 10,398 shares of the company's stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 over the last quarter. 0.28% of the stock is owned by company insiders.

Analyst Ratings Changes

UNH has been the topic of several analyst reports. Robert W. Baird cut UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price objective on the stock. in a research note on Wednesday. Morgan Stanley cut their price target on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Oppenheimer cut their price target on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 14th. Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Finally, Royal Bank of Canada dropped their price objective on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $426.52.

UnitedHealth Group Stock Down 1.6%

UNH stock traded down $5.11 during trading on Friday, reaching $313.39. The stock had a trading volume of 13,729,200 shares, compared to its average volume of 7,201,840. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $284.28 billion, a P/E ratio of 20.22, a PEG ratio of 1.37 and a beta of 0.45. The firm has a fifty day moving average price of $386.66 and a 200 day moving average price of $473.26.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the company posted $6.91 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.82%. UnitedHealth Group's dividend payout ratio is 37.02%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.